Aardvark Therapeutics, Inc. ($AARD)
Filing Information
| Accession Number | 0001193125-26-389564 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 12, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
76,754
Total Value
$394,957.45
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial&Operating Officer | Common Stock, par value $0.00001 per share | โ | Sep 10, 2026 | Sale | 14,754 | $5.00 | $73,778.85 | 97,475 | Direct | โ | View Details | |
Chief Financial&Operating Officer | Common Stock, par value $0.00001 per share | โ | Sep 11, 2026 | Sale | 62,000 | $5.18 | $321,178.60 | 35,475 | Direct | โ | View Details |